File name : Supplementary Information Description : Supplementary figures and supplementary table . File name : Supplementary Data 1 Description : Mass spectrometry peptides . Raw peptide identifications are provided for each sample . Each tab represents an individual mass spectrometry run , and is labeled with the sample name , treatment condition , and treatment duration . Target Site + 1kB + 2kB CSA IP CSP IP β - globin Promoter Binding by CLOuD - 9 Constructs 0 . 25 0 . 20 0 . 15 0 . 10 0 . 05 0 . 00 % I npu t Supplementary Fig . 1 Distance from CLOuD9 binding site Supplementary Figure 1 . CLOuD9 constructs localize to their intended target regions . Chromatin immunoprecipitation and quantitative PCR of CLOuD9 constructs demonstrates correct localization to their intended genomic loci . IB : α - HA S . pyogenes IB : α - Flag S . aureus I npu t N on - B i nd i ng E l u t e IP : α - HA S . Pyogenes Dimerized Control Dimerized Control DimerizerWashout ControlWashout DimerizerWashout Control Washout IB : α - HA S . pyogenes IB : α - Flag S . aureus K562 72hr Treatment and Washout Supplementary Fig . 2 Supplementary Figure 2 . CLOuD9 constructs reversibly associate in response to ABA treatment . Co - immunoprecipitations demonstrating association of the dCas9 proteins following 72 hours of ABA treatment is reversed following subsequent 72 hours of ligand washout . β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 293T 24hr Control and Washout 5 4 3 2 1 0 - 1 R e l a t i v e C r o ss li n k i ng F r equ e n cy DMSOTreatedDMSOWashout 5240000 5260000 5280000 5300000 5320000 β δ G γ A γ ε 1 23 45 LCR HS 5240000 5260000 5280000 5300000 5320000 K562 24hr Control and Washout β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 5 4 3 2 1 0 - 1 R e l a t i v e C r o ss li n k i ng F r equen cy DMSOTreatedDMSOWashout β δ G γ A γ ε 1 23 45 LCR HS Supplementary Fig . 3 Supplementary Figure 3 . Control treatment induces no changes in chromatin contacts . Treatment with DMSO , a control agent , for 24 hours induces no changes in the endogenous chromatin conformation by 3C in either K562 cells or HEK 293Ts . 3C values were normalized to tubulin , and interaction frequencies between the anchor fragment and the fragment encompassing the β / HS fragment were set to zero . Error bars indicate SD . n = 3 . ABA Treated DMSO Treated β - Globin Promoter Targeting Constructs β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 5 4 3 2 1 0 - 1 R e l a t i v e C r o ss li n k i n g F r equen cy β δ G γ A γ ε 1 2345 LCR HS 5240000 5260000 5280000 5300000 5320000 LCR Targeting Constructs β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 5 4 3 2 1 0 - 1 R e l a t i v e C r o ss li n k i ng F r equen cy ABA Treated DMSO Treated 5240000 5260000 5280000 5300000 5320000 β δ G γ A γ ε 1 2 3 4 5 LCR HS Supplementary Fig . 4 Supplementary Figure 4 . Control CLOuD9 transduced cells show no alterations in chromatin looping . Directing two CLOuD9 constructs to either the LCR or the β - globin promoter induces no significant changes in chromatin structure by 3C following ABA treatment relative to control treatment . 3C values were normalized to tubulin , and interaction frequencies between the anchor fragment and the fragment encompassing the β / HS fragment were set to zero . Error bars indicate SD . n = 3 . 5240000 5260000 5280000 5300000 5320000 72hr K562 Dimerized and Washout β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 5 4 3 2 1 0 - 1 R e l a t i v e C r o ss li n k i ng F r equen cy ABA Treated ABA Washout β δ G γ A γ ε 1 2 3 4 5 LCR HS 5240000 5260000 5280000 5300000 5320000 72hr K562 Control and Washout β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 5 4 3 2 1 0 - 1 R e l a t i v e C r o ss li n k i n g F r equen cy DMSO Treated DMSO Washout β δ G γ A γ ε 1 2 3 4 5 LCR HS Supplementary Fig . 5 Supplementary Figure 5 . CLOuD9 chromatin looping remains reversible after 72 hours of dimerization . 3C assay in K562s demonstrates reversibility of CLOuD9 induced β - globin / LCR contacts after 72 hours of ABA treatment . 3C values were normalized to tubulin , and interaction frequencies between the anchor fragment and the fragment encompassing the β / HS fragment were set to zero . Error bars indicate SD . n = 3 . Supplementary Fig . 6 - 1 0 1 2 3 4 5 K562 Guide Pair 2 - 72hr ABA Treated and Washout R e l a t i v e C r o ss - li n k i ng F r equen cy β δ G γ A γ ε 1 2345 LCR HS β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 5240000 5260000 52800005300000 5320000 ABA Treated ABA Washout β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 - 1 0 1 2 3 4 5 R e l a t i v e C r o ss - li n k i ng F r equen cy 5240000 5260000 52800005300000 5320000 β δ G γ A γ ε 1 2345 LCR HS K562 Guide Pair 2 - 72hr DMSO Treated and Washout DMSO Treated DMSO Washout Supplementary Figure 6 . CLOuD9 induced β - globin / LCR looping is not impacted by globin target site . Directing CSA and CSP constructs to alternate regions of the LCR or the β - globin promoter results in similar reversible changes in loop induction by 3C following 72 hours of ABA treatment . 3C values were normalized to tubulin , and interaction frequencies between the anchor fragment and the fragment encompassing the β / HS fragment were set to zero . Error bars indicate SD . n = 3 . Supplementary Fig . 7 K562 Guide Pair 2 - β - globin Expression 0 2 4 6 8 10 20 25 30 35 ABA Washout ABA Treated * * * n . s . Treatment Condition F o l d C hange R e l a t i v e t o C on t r o l T r ea t ed C e ll s * * * * * 10 Day 72 hour Supplementary Figure 7 . CLOuD9 induced alterations in gene expression are sustained regardless of globin target site . Directing CSA and CSP constructs to alternate regions of the β - globin promoter and LCR has no impact on induction of gene expression following 72 hours of dimerization . However , while some impact on the strength of gene expression following long - term ( 10 day ) dimerization was observed , high levels of β - globin relative to control treated cells were sustained following subsequent ligand washout for 10 additional days . Significance given relative to control treated cells . * * p < 0 . 001 , t = 10 . 25 , df = 5 ; * * * p < 0 . 0001 , left to right t = 8 . 697 , df = 6 , t = 40 . 31 , df = 7 ; n . s . non - significant . All error bars indicate SD . Supplementary Fig . 8 1 . 5 1 . 0 0 . 5 0 . 0 β - Globin Expression F o l d C hange R e l a t i v e t o C on t r o l T r ea t e d C e ll s LCR Targeting Constructs β - Globin Promoter Targeting Constructs Cell Line n . s . n . s . Supplementary Figure 8 . Control CLOuD9 transduced cells show no alterations in β - globin expression . Directing two CLOuD9 constructs to either the LCR or the β - globin promoter induces no significant changes in β - globin expression following ABA treatment relative to control treatment . Significance given relative to control treated cells . n . s . non - significant . β δ G γ A γ ε 1 23 45 LCR HS 5240000 5260000 5280000 5300000 5320000 K562 10 Day Dimerized and Washout β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 5 4 3 2 1 0 - 1 R e l a t i v e C r o ss li n k i ng F r equen cy DMSO Treated DMSO Washout Supplementary Fig . 9 β δ G γ A γ ε 1 23 45 LCR HS 293T 10 Day Dimerized and Washout 5 4 3 2 1 0 - 1 R e l a t i v e C r o ss li n k i ng F r e qu en cy DMSO Treated DMSO Washout 5240000 5260000 5280000 5300000 5320000 β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 Supplementary Figure 9 . Long - term control treatment induces no changes in chromatin contacts . Treatment with DMSO , a control agent , for 10 days induces no change in endogenous chromatin conformation by 3C in either K562 cells or HEK 293Ts . 3C values were normalized to tubulin , and interaction frequencies between the anchor fragment and the fragment encompassing the β / HS fragment were set to zero . Error bars indicate SD . n = 3 . Supplementary Fig . 10 - 1 0 1 2 3 4 5 K562 Guide Pair 2 - 10 Day ABA Treated and Washout R e l a t i v e C r o ss - li n k i ng F r equen cy β δ G γ A γ ε 1 2345 LCR HS β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 5240000 5260000 52800005300000 5320000 ABA Treated ABA Washout β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 - 1 0 1 2 3 4 5 R e l a t i v e C r o ss - li n k i ng F r equen cy 5240000 5260000 52800005300000 5320000 β δ G γ A γ ε 1 2345 LCR HS K562 Guide Pair 2 - 10 Day DMSO Treated and Washout DMSO Treated DMSO Washout Supplementary Figure 10 . Long - term CLOuD9 induced β - globin / LCR looping is not impacted by globin target site . Directing CSA and CSP constructs to alternate regions of the LCR or the β - globin promoter results in similarly sustained loop induction as demonstrated by 3C following 10 days of ABA treatment and 10 days of subsequent ligand washout . 3C values were normalized to tubulin , and interaction frequencies between the anchor fragment and the fragment encompassing the β / HS fragment were set to zero . Error bars indicate SD . n = 3 . IB : α - HA S . pyogenes IB : α - Flag S . aureus I npu t N on - B i nd i ng E l u t e IP : α - HA S . Pyogenes Dimerized Control Dimerized Control DimerizerWashout ControlWashout DimerizerWashout Control Washout IB : α - HA S . pyogenes IB : α - Flag S . aureus K562 10 Day Treatment and Washout Supplementary Fig . 11 Supplementary Figure 11 . CLOuD9 constructs irreversibly associate in response to long - term ABA treatment . Co - immunoprecipitations demonstrating irreversible association of the CSA and CSP dCas9 proteins following 10 days of ABA treatment and 10 subsequent days of ligand washout . Supplementary Fig . 12 250 150 10075 50 37 2520 kDa IP : α - HA ( S . Pyogenes ) IB : α - CTCF I npu t N on - B i nd i ng E l u t e I npu t N on - B i nd i ng E l u t e I npu t N on - B i nd i ng E l u t e I npu t N on - B i nd i ng E l u t e 72 hours Dimerized 72 hours Control 10 Days Dimerized 10 Days Control 250 150 10075 50 37 25 kDa I npu t N on - B i nd i ng E l u t e I npu t N on - B i nd i ng E l u t e I npu t N on - B i nd i ng E l u t e I npu t N on - B i nd i ng E l u t e IP : α - HA ( S . Pyogenes ) IB : α - SMC1 72 hours Dimerized 72 hours Control 10 Days Dimerized 10 Days Control Supplementary Figure 12 . Uncropped images of immunoblots in Fig 4b . Immunoprecipitation of CLOuD9 complexes demonstrates that CTCF and cohesin were not found to be localized to the induced loops . IB : α - DDX5 IB : α - DDX17 I npu t N on - B i nd i ng E l u t e IP : α - DDX5 Dimerized Control Dimerized Control K562 10 Day Treatment Supplementary Fig . 13 Supplementary Figure 13 . RNA helicases DDX5 and DDX17 co - associate . Co - immunoprecipitations demonstrating DDX17 associates with DDX5 in K562 cells regardless of treatment condition . Supplementary Fig . 14 K562 10 Day Treatment DDX5 ChIP - qPCR 0 . 05 0 . 10 0 . 15 0 . 20 * * * * * * * * * * Distance from CLOuD9 Binding Site P e r c en t I npu t ABA Treatment Control Treatment + 25bp + 100bp + 25bp + 100bp CSP Negative Control CSA Negative Control CSA CSP Supplementary Figure 14 . RNA helicases DDX5 and DDX17 localize to CLOuD9 target regions . Chromatin immunoprecipitation and quantitative PCR of CLOuD9 constructs demonstrates their localization to regions of chromatin immediately adjacent to CLOuD9 target sites . * p < 0 . 05 , t = 2 . 662 , df = 14 ; * * * p < 0 . 0001 , left to right t = 4 . 1 , df = 14 , t = 6 . 659 , df = 14 ; t = 4 . 392 , df = 14 . All error bars indicate SD . Supplementary Fig . 15 250 150 10075 50 37 2520 kDa 250 150 10075 50 37 2520 kDa 250 150 10075 50 37 2520 kDa α - DDX5 α - DDX17 α - actin Supplementary Figure 15 . Uncropped images of immunoblots in Fig 4c . shRNA knockdown of DDX5 and DDX17 in K562s containing CLOuD9 constructs . Supplementary Fig . 16 - 1 0 1 2 3 4 5 DDX5 shRNA 72hr DMSO Treated and Washout R e l a t i v e C r o ss - li n k i ng F r equen cy β δ G γ A γ ε 1 2345 LCR HS β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 5240000 5260000 52800005300000 5320000 DMSO Treated DMSO Washout β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 - 1 0 1 2 3 4 5 R e l a t i v e C r o ss - li n k i ng F r equen cy 5240000 5260000 52800005300000 5320000 β δ G γ A γ ε 1 2345 LCR HS DDX17 shRNA 72hr DMSO Treated and Washout DMSO Treated DMSO Washout Supplementary Figure 16 . Control treatment of DDX5 and DDX17 knockdown CLOuD9 cells induces no changes in chromatin contacts . Treatment with DMSO , a control agent , for 72 hours induces no changes in endogenous chromatin conformation by 3C in DDX5 or DDX17 knockdown K562 cells . 3C values were normalized to tubulin , and interaction frequencies between the anchor fragment and the fragment encompassing the β / HS fragment were set to zero . Error bars indicate SD . n = 3 . Supplementary Fig . 17 β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 - 1 0 1 2 3 4 5 R e l a t i v e C r o ss - li n k i ng F r equen cy 5240000 5260000 52800005300000 5320000 β δ G γ A γ ε 1 2345 LCR HS DDX5 shRNA 10 Day DMSO Treated and Washout DMSO Treated DMSO Washout β / H S 3 ΄ β β Δ G γ A γ ε γ H 432 - 1 0 1 2 3 4 5 R e l a t i v e C r o ss - li n k i ng F r equen cy 5240000 5260000 52800005300000 5320000 β δ G γ A γ ε 1 2345 LCR HS DDX17 shRNA 10 Day DMSO Treated and Washout DMSO Treated DMSO Washout Supplementary Figure 17 . Long - term control treatment of DDX5 and DDX17 knockdown CLOuD9 cells induces no changes in chromatin contacts . Treatment with DMSO , a control agent , for 10 days induces no changes in endogenous chromatin conformation by 3C in DDX5 or DDX17 knockdown K562 cells . 3C values were normalized to tubulin , and interaction frequencies between the anchor fragment and the fragment encompassing the β / HS fragment were set to zero . Error bars indicate SD . n = 3 . Supplementary Table 1 . List of primer sequences for gRNAs , qRT - PCR , 3C , and ChIP qPCR . gRNA Sequences Name Sequence 5’ - 3’ CLOuD9 Construct HBB Promoter Pair 1 TAGTCTGGGTATACTTAGAGG CSA LCR Pair 1 CTAGAGTGATGACTCCTATC CSP HBB Promoter Pair 2 AAGTTGATGCACTAAAAGTGG CSA LCR Pair 2 AATATGTCACATTCTGTCTC CSP Oct4 Promoter CTTATGGCTGTTGATGCATTG CSA Oct4 Distal 5’Enhancer CTCTTTGGATCGCGTCACTC CSP qPCR Primers Primer Forward 5’ - 3’ Reverse 5’ - 3’ β - globin TGGGCAACCCTAAGGTGAAG GTGAGCCAGGCCATCACTAAA Oct4 TGTACTCCTCGGTCCCTTTC TCCAGGTTTTCTTTCCCTAGC GapDH ACCACAGTCCATGCCATCACT CCATCACGCCACAGTTTCC 3C Primers β - globin Name Primer Sequence 5’ - 3’ 3C B / HS TCTTAGAAAGCCTTTACAATTTCCTTTATC 3C 3 Beta AGCTTAGTGATACTTGTGGGCCA 3C Beta GCTCGGCACATGTCCCATCCAG 3C Delta AAAAAATGTGGAATTAGACCCAGGAATG 3C 5 Delta GGGTGTGTATTTGTCTGCCA 3C G / A AATTTGAAGATACAGCTTGCCTCCGATAAG 3C Gg GGGTTCATCTTTATTGTCTCCT 3C E / G CCACCCCGATAAAGATTTTTCTCCATCA 3C HS432 CCAAATGGGTGACTGTAGGGTTGAGA 3 ' HS1 ATTCCCGTTTTTATGAAATCAACTTT 3 ' 3 ' HS1 CTCATAGATTTCTCAATGGCCAAA Oct4 Name Primer Sequence 5’ - 3’ PromoterF1 TGTGCCTTCAGGGGCCAGTC PromoterF2 AGTCACCCTCTCAGCTCCTCA PromoterR1 TGGGGTGAAATTTGGCAGGCT PromoterR2 AGGCTGGGCAGATGGTGCCA 5’EnhF1 CAAAGTCACACTGCACCCGCT 5’EnhF2 ATGTGGCTCCCTCCCATGTAC 5’EnhR1 CACTGGCAAGGATTATCTCATG 5’EnhR2 TGTGTCCAGTTGCCAAATGAGG DistalEnhF1 CAGGGCACACACACTTTTGCAG DistalEnhF2 GTATCCAAAAACCCAAGCCAGGTC DistalEnhR1 TAGCAGGCCCCCAAGGAGGA DistalEnhR2 ACTGGGAAGGAACTGGCACT 3’EnhF1 TGCCATTACCATCCCACGGT 3’EnhF2 CTAGGGGAGAAGCCCGGGTTG 3’EnhR1 TGGTCCCCACTTCCCCAGGTG 3’EnhR2 GCGGGAACAGGCAGGCTCT ChIP qPCR Primers Name Primer Sequence 5 ' - 3 ' HBB 7F1 CAACAAGGTGCCAAGTCTTTT HBB 7R1 ACATCACCTGGATGGGACAT HBB 13F1 GAATGGCCCTAGTCTGGGTA HBB 13R1 TGCTGCTTTTGAAACAAATGA HBB 10F1 CCTATGGCAAAAATGGTGCT HBB 10R1 CATGCAGTAAACAACCGAACA C5 1F2 TTTGCCATCTGCCCTGTAAG C5 1R2 AGTCATGCTGAGGCTTAGGG C5 6F1 TCAGCTCTGCCTTTCTCCTC C5 6R1 GCAGACCTTAACTGGCATCC C5 8F1 CAGTTGCATGCTACCTTAAAGA C5 8R1 AAGCTGAATCTGCTGCCAAC DistalHBBF GCCGTAAAACATGGAAGGAA DistalHBBR CCCATTTGCTTATCCTGCAT 3’HBBF TTCCAGAATCTAGCATCTACCTACC 3’HBBR TGCTTCTGGCTCTGCAGTTA HBBF GCAAGAAAGCGAGCTTAGTGA HBBR CAAAGAATTCACCCCACCAG 5’HBBF CCTCACCACCAACTTCATCC 5’HBBR GCAACCTCAAACAGACACCA Proximal PromF TAGATGGCTCTGCCCTGACT Proximal PromR CACTTAGACCTCACCCTGTGG Distal PromF TGGGGTAATCAGTGGTGTCA Distal PromR TTTTGTTCCCCCAGACACTC Positive Control1F ACCCTTCAGCAGTTCCACAC Positive Control1R ACCCTTCAGCAGTTCCACAC Positive Control2F TGGTATTTTATTCTGAAACACAGAGG Positive Control2R GCTTCGGTGTTCAGTGGATT Negative ControlF CCCAAATGAGATTATGCCACTG Negative ControlR CTATGTTTGTGTTGCAGAGCCC